, a global provider in specialty logistics and an 

 company, has been granted Wholesale Distribution Authorization (WDA) by the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA). The WDA is a benchmark certifying the company’s quality systems and processes for storing and distributing pharmaceuticals.

	Designed to ensure patients and patients in clinical trials safely receive their proper medications, the regulation serves as a verification measure to enforce the European Union’s Falsified Medicine Directive. MHRA regulations require WDA for companies that store shipments of pharmaceutical products for longer than 36 hours or have a refrigerated storage facility for pharmaceuticals. The company also met requirements to demonstrate compliance with the European Union’s Good Distribution Practice (GDP), guidelines that regulate the storage and transportation of medicinal products intended for human consumption.

News

Designed to ensure patients and patients in clinical trials safely receive their proper medications, the regulation serves as a verification measure to enforce the European Union’s Falsified Medicine Directive.